BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22529293)

  • 1. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
    Mills JH; Kim DG; Krenz A; Chen JF; Bynoe MS
    J Immunol; 2012 Jun; 188(11):5713-22. PubMed ID: 22529293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
    Mills JH; Alabanza LM; Mahamed DA; Bynoe MS
    J Neuroinflammation; 2012 Aug; 9():193. PubMed ID: 22883932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Never underestimate the power of adenosine in multiple sclerosis.
    Volonté C
    CNS Neurol Disord Drug Targets; 2013 Nov; 12(7):895-6. PubMed ID: 24040797
    [No Abstract]   [Full Text] [Related]  

  • 4. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels.
    Liu Y; Zou H; Zhao P; Sun B; Wang J; Kong Q; Mu L; Zhao S; Wang G; Wang D; Zhang Y; Zhao J; Yin P; Liu L; Zhao X; Li H
    Neuroscience; 2016 Aug; 330():150-61. PubMed ID: 27217214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling.
    Tsiperson V; Gruber RC; Goldberg MF; Jordan A; Weinger JG; Macian F; Shafit-Zagardo B
    J Immunol; 2013 Feb; 190(4):1528-39. PubMed ID: 23335751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
    Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
    J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of A2A adenosine receptor in traumatic optic neuropathy.
    Ahmad S; Fatteh N; El-Sherbiny NM; Naime M; Ibrahim AS; El-Sherbini AM; El-Shafey SA; Khan S; Fulzele S; Gonzales J; Liou GI
    J Neuroimmunol; 2013 Nov; 264(1-2):54-64. PubMed ID: 24090652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.
    Mills JH; Thompson LF; Mueller C; Waickman AT; Jalkanen S; Niemela J; Airas L; Bynoe MS
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9325-30. PubMed ID: 18591671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis.
    Rajasundaram S
    Front Immunol; 2018; 9():402. PubMed ID: 29559972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
    Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
    Front Immunol; 2021; 12():792465. PubMed ID: 34975892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.